Gene therapy from Chinese firm HuidaGene killed a child: study

Gene therapy developed by Chinese biotech firm HuidaGene showed promise in animal trials but triggered a fatal reaction in a child. Results published in Nature indicate the treatment's effectiveness was limited. The case reignites debate over the safety of experimental gene therapies in humans.